96444-49-4Relevant academic research and scientific papers
3-(PYRIMIDINE-2-YL)IMIDAZO[1,2-A]PYRIDINES
-
, (2017/04/04)
The present application relates to novel 3-(pyrimidin-2-yl)imidazo[1,2-a]pyridines, to processes for preparation thereof, to the use thereof, alone or in combinations, for the treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of cardiovascular disorders.
Antinuclear Agents. 1. Gastric Antisecretory and Cytoprotective Properties of Substituted Imidazopyridines
Kaminski, James J.,Bristol, James A.,Puchalski, Chester,Lovey, Raymond G.,Elliott, Arthur J.,et al.
, p. 876 - 892 (2007/10/02)
A novel class of antinuclear agents, the substituted imidazopyridines, is described.The present compounds are not histamine (H2) receptor antagonists nor are they prostaglandin analoques, yet they exhibit both gastric antisecretory and c
